Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin + sulfonylurea in Japanese type 2 diabetes
NCT00974090Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Mitsubishi Tanabe Pharma. Started Sep 2009; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00974090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974090.